Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The two objectives of this study were to evaluate long-term efficacy and safety of adalimumab
treatment in participants who had moderate to severe chronic plaque psoriasis and to evaluate
the effectiveness of adalimumab retreatment in participants who had therapeutic response to
adalimumab and were then withdrawn from adalimumab treatment.